| 2VXR | A:1089-1298 | CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN |
| 3AZV | A:1077-1284; B:1077-1284 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN |
| 3AZW | A:1077-1284; B:1077-1284 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN |
| 3FUQ | A:1086-1278 | GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F |
| 3MPP | G:1090-1299 | BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN |
| 3N7J | A:1068-1276 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN |
| 3N7K | A:1094-1290; B:1094-1290 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN |
| 3N7L | A:1077-1284 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN |
| 3N7M | A:1077-1284 | CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 |
| 3OGG | A:1068-1276 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D |
| 3PME | A:1086-1284 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE |
| 3R4S | A:1094-1291; B:1094-1291 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3R4U | A:1094-1291; B:1094-1291 | CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES |
| 3RMX | A:1068-1276; B:1068-1276; C:1068-1276; D:1068-1276 | CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT |
| 3RMY | A:1068-1276; B:1068-1276; C:1068-1276; D:1068-1276 | CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT |
| 3RSJ | A:1086-1278; B:1086-1278; C:1086-1278; D:1086-1278 | STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A |
| 4F83 | A:1072-1282 | CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE |
| 4FVV | A:1077-1283; B:1077-1283 | CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C |
| 4IQP | A:1094-1296 | CRYSTAL STRUCTURE OF HCRA-W1266A |
)
)